MarketCap
Facebook
X
Telegram
Sorrento Therapeutics EV/EBITDA Ratio | SRNE
Annual EV/EBITDA Ratio Sorrento Therapeutics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.959 | -3.41 | -11 | -3.18 | -3.36 | 27.7 | -5.27 | -5.4 | -9.68 | -8.22 | 0.976 | -829 | 2.95 | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 27.7 | -829 | -65.2 |
EV/EBITDA Ratio of other stocks in the Biotechnology industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Mustang Bio
MBIO
|
2.1 | $ 0.44 | 12.95 % | $ 2.16 M |  USA |
 |
Cerevel Therapeutics Holdings
CERE
|
-15.5 | - | - | $ 7.29 B | USA |
 |
NexImmune
NEXI
|
-0.173 | - | 70.13 % | $ 4.12 M | USA |
 |
Codexis
CDXS
|
-4.31 | $ 1.0 | -9.91 % | $ 87.1 M | USA |
 |
Theravance Biopharma
TBPH
|
26.7 | $ 17.03 | 0.03 % | $ 857 M |  Cayman-islands |
 |
Compugen Ltd.
CGEN
|
3.32 | $ 2.06 | -3.72 % | $ 192 M |  Israel |
 |
IMV
IMV
|
-3.88 | - | - | $ 13.1 M |  Canada |
 |
Sanofi
SNY
|
8.13 | $ 48.23 | 0.22 % | $ 58.9 B |  France |
 |
Karuna Therapeutics
KRTX
|
-23.7 | - | - | $ 12.2 B | USA |
 |
Chimerix
CMRX
|
0.0697 | - | - | $ 756 M | USA |
 |
Atreca
BCEL
|
17.4 | - | -11.76 % | $ 5.79 M | USA |
 |
LogicBio Therapeutics
LOGC
|
-1.39 | - | - | $ 229 M | USA |
 |
RedHill Biopharma Ltd.
RDHL
|
-1.65 K | $ 0.38 | -5.06 % | $ 4.68 B | Israel |
|
89bio
ETNB
|
-2.41 | - | - | $ 1.55 B | USA |
 |
Fusion Pharmaceuticals
FUSN
|
-14.2 | - | - | $ 1.41 B | Canada |
 |
Gritstone Oncology
GRTS
|
-2.57 | - | 0.42 % | $ 213 M | USA |
 |
Harpoon Therapeutics
HARP
|
-0.58 | - | - | $ 763 M | USA |
 |
HOOKIPA Pharma
HOOK
|
0.172 | - | -6.92 % | $ 79.4 M | USA |
 |
Guardion Health Sciences
GHSI
|
0.599 | - | -0.31 % | $ 3.64 M | USA |
 |
Opiant Pharmaceuticals
OPNT
|
19.5 | - | - | $ 109 M | USA |
 |
Akouos
AKUS
|
-1.27 | - | 0.23 % | $ 488 M | USA |
 |
Otonomy
OTIC
|
-1.86 | - | -1.96 % | $ 4.68 M | USA |
 |
Aridis Pharmaceuticals
ARDS
|
-1.29 | - | 17.91 % | $ 11.1 M | USA |
 |
Seagen
SGEN
|
-45.9 | - | - | $ 42.2 B | USA |
|
Protara Therapeutics
TARA
|
-3.24 | $ 2.44 | -2.59 % | $ 105 M | USA |
 |
Baudax Bio
BXRX
|
-1.67 | - | 0.59 % | $ 63 K | USA |
 |
ChemoCentryx
CCXI
|
-0.721 | - | - | $ 3.74 B | USA |
 |
Avid Bioservices
CDMO
|
-87.3 | - | - | $ 789 M | USA |
 |
Zosano Pharma Corporation
ZSAN
|
-1.92 | - | 7.23 % | $ 2.72 M | USA |
 |
Oncternal Therapeutics
ONCT
|
-0.654 | - | -24.12 % | $ 1.56 M | USA |
 |
Iterum Therapeutics
ITRM
|
-2.81 | - | - | $ 591 K |  Irlanda |
 |
Spectrum Pharmaceuticals
SPPI
|
-2.18 | - | - | $ 189 M | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
-0.268 | - | - | $ 26.5 M | USA |
 |
Alpine Immune Sciences
ALPN
|
-0.183 | - | - | $ 2.17 B | USA |
 |
Concert Pharmaceuticals
CNCE
|
-0.207 | - | - | $ 401 M | USA |
 |
ImmunoGen
IMGN
|
-4.27 | - | - | $ 7.92 B | USA |
 |
Vascular Biogenics Ltd.
VBLT
|
0.477 | - | -8.77 % | $ 12.4 M | Israel |
 |
Histogen
HSTO
|
0.305 | - | 31.6 % | $ 2.12 M | USA |
 |
Berkeley Lights
BLI
|
-1.29 | - | -7.31 % | $ 87 M | USA |
 |
Cidara Therapeutics
CDTX
|
-0.0568 | - | - | $ 1.41 B | USA |
 |
Clovis Oncology
CLVS
|
-19.7 | - | -7.23 % | $ 13 M | USA |
 |
Kaleido Biosciences
KLDO
|
-0.876 | - | -3.69 % | $ 12.4 M | USA |
 |
VBI Vaccines
VBIV
|
0.18 | - | -50.87 % | $ 1.09 M | USA |
 |
CTI BioPharma Corp.
CTIC
|
-8.52 | - | - | $ 1.2 B | USA |
 |
Decibel Therapeutics
DBTX
|
-1.75 | - | - | $ 123 M | USA |
 |
NuCana plc
NCNA
|
-4.24 K | $ 0.94 | -2.67 % | $ 10.6 B |  Britain |
 |
PhaseBio Pharmaceuticals
PHAS
|
-2.14 | - | 7.4 % | $ 6.29 M | USA |
 |
Provention Bio
PRVB
|
-14.6 | - | - | $ 2.37 B | USA |
 |
IVERIC bio
ISEE
|
-13.8 | - | - | $ 5.51 B | USA |
 |
Reata Pharmaceuticals
RETA
|
1.42 K | - | - | $ 6.29 B | USA |